XML 70 R59.htm IDEA: XBRL DOCUMENT
v3.25.1

REVENUES - Principal Activities (Details) - USD ($) $ in Millions | 3 Months Ended |
--- | --- | ---
Mar. 31, 2025 | Mar. 31, 2024 | Dec. 31, 2024
Disaggregation of revenue |  |  |
Net sales | $ 3,695.0 | $ 3,751.9 |
Allowance for expected return of products | $ 45.6 |  | $ 52.5
United States | Geographic concentration | Consolidated net sales |  |  |
Disaggregation of revenue |  |  |
Percentage of consolidated sales | 54.00% | 53.00% |
Product and equipment sales |  |  |
Disaggregation of revenue |  |  |
Net sales | $ 2,901.9 | $ 2,986.5 |
Service and lease sales |  |  |
Disaggregation of revenue |  |  |
Net sales | 793.1 | 765.4 |
Operating segment |  |  |
Disaggregation of revenue |  |  |
Net sales | 3,652.1 | 3,621.5 |
Global Water |  |  |
Disaggregation of revenue |  |  |
Net sales | 1,826.4 | 1,838.9 |
Global Water | United States |  |  |
Disaggregation of revenue |  |  |
Net sales | 816.9 | 791.0 |
Global Water | Europe |  |  |
Disaggregation of revenue |  |  |
Net sales | 356.3 | 363.3 |
Global Water | Asia Pacific |  |  |
Disaggregation of revenue |  |  |
Net sales | 221.0 | 230.4 |
Global Water | Latin America |  |  |
Disaggregation of revenue |  |  |
Net sales | 180.3 | 196.2 |
Global Water | Greater China |  |  |
Disaggregation of revenue |  |  |
Net sales | 98.2 | 99.0 |
Global Water | India, Middle East and Africa |  |  |
Disaggregation of revenue |  |  |
Net sales | 100.0 | 106.1 |
Global Water | Canada |  |  |
Disaggregation of revenue |  |  |
Net sales | 53.7 | 52.9 |
Global Water | Product and equipment sales |  |  |
Disaggregation of revenue |  |  |
Net sales | 1,600.3 | 1,612.2 |
Global Water | Service and lease sales |  |  |
Disaggregation of revenue |  |  |
Net sales | 226.1 | 226.7 |
Global Water | Operating segment |  |  |
Disaggregation of revenue |  |  |
Net sales | 1,800.5 | 1,755.0 |
Global Institutional and Specialty |  |  |
Disaggregation of revenue |  |  |
Net sales | 1,418.0 | 1,480.2 |
Global Institutional and Specialty | United States |  |  |
Disaggregation of revenue |  |  |
Net sales | 938.5 | 974.1 |
Global Institutional and Specialty | Europe |  |  |
Disaggregation of revenue |  |  |
Net sales | 226.0 | 245.6 |
Global Institutional and Specialty | Asia Pacific |  |  |
Disaggregation of revenue |  |  |
Net sales | 75.2 | 78.6 |
Global Institutional and Specialty | Latin America |  |  |
Disaggregation of revenue |  |  |
Net sales | 49.2 | 55.1 |
Global Institutional and Specialty | Greater China |  |  |
Disaggregation of revenue |  |  |
Net sales | 49.8 | 46.8 |
Global Institutional and Specialty | India, Middle East and Africa |  |  |
Disaggregation of revenue |  |  |
Net sales | 21.8 | 21.5 |
Global Institutional and Specialty | Canada |  |  |
Disaggregation of revenue |  |  |
Net sales | 57.5 | 58.5 |
Global Institutional and Specialty | Product and equipment sales |  |  |
Disaggregation of revenue |  |  |
Net sales | 1,140.3 | 1,215.2 |
Global Institutional and Specialty | Service and lease sales |  |  |
Disaggregation of revenue |  |  |
Net sales | 277.7 | 265.0 |
Global Institutional and Specialty | Operating segment |  |  |
Disaggregation of revenue |  |  |
Net sales | 1,406.5 | 1,446.9 |
Global Life Sciences |  |  |
Disaggregation of revenue |  |  |
Net sales | 170.0 | 166.7 |
Global Life Sciences | United States |  |  |
Disaggregation of revenue |  |  |
Net sales | 49.1 | 45.4 |
Global Life Sciences | Europe |  |  |
Disaggregation of revenue |  |  |
Net sales | 85.8 | 96.3 |
Global Life Sciences | Asia Pacific |  |  |
Disaggregation of revenue |  |  |
Net sales | 10.3 | 7.5 |
Global Life Sciences | Latin America |  |  |
Disaggregation of revenue |  |  |
Net sales | 5.1 | 4.5 |
Global Life Sciences | Greater China |  |  |
Disaggregation of revenue |  |  |
Net sales | 11.5 | 9.4 |
Global Life Sciences | India, Middle East and Africa |  |  |
Disaggregation of revenue |  |  |
Net sales | 7.3 | 3.1 |
Global Life Sciences | Canada |  |  |
Disaggregation of revenue |  |  |
Net sales | 0.9 | 0.5 |
Global Life Sciences | Product and equipment sales |  |  |
Disaggregation of revenue |  |  |
Net sales | 161.3 | 159.1 |
Global Life Sciences | Service and lease sales |  |  |
Disaggregation of revenue |  |  |
Net sales | 8.7 | 7.6 |
Global Life Sciences | Operating segment |  |  |
Disaggregation of revenue |  |  |
Net sales | 167.0 | 159.3 |
Global Pest Elimination |  |  |
Disaggregation of revenue |  |  |
Net sales | 280.6 | 266.1 |
Global Pest Elimination | United States |  |  |
Disaggregation of revenue |  |  |
Net sales | 195.2 | 181.7 |
Global Pest Elimination | Europe |  |  |
Disaggregation of revenue |  |  |
Net sales | 44.3 | 43.2 |
Global Pest Elimination | Asia Pacific |  |  |
Disaggregation of revenue |  |  |
Net sales | 7.9 | 7.6 |
Global Pest Elimination | Latin America |  |  |
Disaggregation of revenue |  |  |
Net sales | 14.1 | 14.5 |
Global Pest Elimination | Greater China |  |  |
Disaggregation of revenue |  |  |
Net sales | 14.7 | 14.7 |
Global Pest Elimination | India, Middle East and Africa |  |  |
Disaggregation of revenue |  |  |
Net sales | 1.7 | 1.7 |
Global Pest Elimination | Canada |  |  |
Disaggregation of revenue |  |  |
Net sales | 2.7 | 2.7 |
Global Pest Elimination | Service and lease sales |  |  |
Disaggregation of revenue |  |  |
Net sales | 280.6 | 266.1 |
Global Pest Elimination | Operating segment |  |  |
Disaggregation of revenue |  |  |
Net sales | $ 278.1 | $ 260.3 |

X
- Definition This element represents the portion of the allowance for doubtful accounts receivable representing the expected return of products shipped and credits related to pricing or quantities shipped. + References No definition available. + Details
Name: | ecl_AllowanceForDoubtfulAccountsReturnsCredits
Namespace Prefix: | ecl_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 42 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 21 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482907/825-10-50-21 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 20 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482907/825-10-50-20 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 275 -SubTopic 10 -Section 50 -Paragraph 18 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482861/275-10-50-18 Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 275 -SubTopic 10 -Section 50 -Paragraph 20 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482861/275-10-50-20 + Details
Name: | us-gaap_ConcentrationRiskPercentage1
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 5 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5 Reference 2: http://www.xbrl.org/2003/role/exampleRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 91 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91 Reference 3: http://www.xbrl.org/2003/role/exampleRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 91 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91 Reference 4: http://www.xbrl.org/2003/role/exampleRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 91 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91 Reference 5: http://www.xbrl.org/2003/role/exampleRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 91 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91 Reference 6: http://www.xbrl.org/2003/role/exampleRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 91 -Subparagraph (e) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91 Reference 7: http://www.xbrl.org/2003/role/exampleRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 91 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91 Reference 8: http://www.xbrl.org/2003/role/exampleRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 91 -Subparagraph (g) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91 + Details
Name: | us-gaap_DisaggregationOfRevenueLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 41 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 270 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (i) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (ee) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32 Reference 4: http://fasb.org/us-gaap/role/ref/otherTransitionRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32 Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 924 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SAB Topic 11.L) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479941/924-10-S99-1 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 5 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 30 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 42 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 22 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22 Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 40 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40 Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 22 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22 Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479806/606-10-50-4 + Details
Name: | us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Details
Name: | srt_StatementGeographicalAxis=country_US
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ConcentrationRiskByTypeAxis=us-gaap_GeographicConcentrationRiskMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ConcentrationRiskByBenchmarkAxis=ecl_SalesRevenueTotalMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=ecl_ProductAndEquipmentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=ecl_ServiceAndLeaseMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=ecl_WaterServicesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_StatementGeographicalAxis=srt_EuropeMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_StatementGeographicalAxis=srt_AsiaPacificMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_StatementGeographicalAxis=srt_LatinAmericaMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_StatementGeographicalAxis=country_CN
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_StatementGeographicalAxis=ecl_IndiaMiddleEastAndAfricaMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_StatementGeographicalAxis=country_CA
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=ecl_GlobalInstitutionalMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=ecl_GlobalHealthcareAndLifeSciencesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=ecl_GlobalPestEliminationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |